Literature DB >> 7215075

"Organic brain syndrome" secondary to 5-fluorouracil toxicity.

H T Lynch, C P Droszcz, W A Albano, J F Lynch.   

Abstract

A 68-year-old woman, who was treated with 5-fluorouracil (5-FU) intravenous therapy weekly for variable periods following hemicolectomy for adenocarcinoma of the cecum, had at least two well-described episodes of mental confusion, disorientation, and deterioration, in the absence of cerebellar tract signs. The sensorium cleared after cessation of 5-FU, only to deteriorate following readministration of the drug. She was thought to have organic brain syndrome during her most recent mental relapse. Her mental status has now been intact for more than one year since her last exposure to 5-FU. This is believed to be the third patient who has shown mental changes which could be attributable to 5-FU toxicity. Since 5-FU is the most frequently used chemotherapy for the treatment of colonic cancer, it is important that this form of toxicity be recognized lest subject patients be judged to have irreversible organic brain syndrome or metastatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7215075     DOI: 10.1007/bf02604302

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Authors:  R B Diasio; T L Beavers; J T Carpenter
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Neuropathologic study on chronic neurotoxicity of 5-fluorouracil and its masked compounds in dogs.

Authors:  R Okeda; T Karakama; S Kimura; S Toizumi; T Mitsushima; Y Yokoyama
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 3.  Subacute leucoencephalopathy induced by carmofur, a 5-fluorouracil derivative.

Authors:  S Kuzuhara; N Ohkoshi; K Kanemaru; H Hashimoto; T Nakanishi; Y Toyokura
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

4.  Intrathecal 5-fluorouracil in the rhesus monkey.

Authors:  S L Berg; F M Balis; C L McCully; G A Parker; R F Murphy; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  A case of neurotoxicity following 5-fluorouracil-based chemotherapy.

Authors:  Seung Seog Ki; Jin Mo Jeong; Seong Ho Kim; Sook Hyang Jeong; Jin Hyuk Lee; Chul Ju Han; You Cheol Kim; Jhin Oh Lee; Young Joon Hong
Journal:  Korean J Intern Med       Date:  2002-03       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.